Financial News, Latest News
Immuron Limited (NASDAQ: IMRN) Revenue Grew 179% While Working to Improve Immune-Related Diseases Immuron Limited (NASDAQ: IMRN), an Australian biopharmaceutical firm, specializes in oral immunotherapeutics designed to manage immune-related diseases. Despite a sharp...